We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.9B
AUM Growth
+$433M
Cap. Flow
+$143M
Cap. Flow %
1.31%
Top 10 Hldgs %
18.12%
Holding
2,433
New
160
Increased
1,129
Reduced
851
Closed
234
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDR
1476
DELISTED
Cloudera, Inc.
CLDR
$460K ﹤0.01%
87,528
+36,765
+72% +$339K
AA icon
1477
Alcoa
AA
$13.1B
$459K ﹤0.01%
19,623
+3,406
+21% +$84.9K
LCII icon
1478
LCI Industries
LCII
$2.6B
$459K ﹤0.01%
5,105
-213
-4% -$18.8K
EMHY icon
1479
iShares JPMorgan EM High Yield Bond ETF
EMHY
$639M
$458K ﹤0.01%
9,585
+3,702
+63% +$172K
PRN icon
1480
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$442M
$458K ﹤0.01%
6,904
-50
-0.7% -$3.17K
TFX icon
1481
Teleflex
TFX
$5.82B
$458K ﹤0.01%
1,383
+141
+11% +$42.6K
GHII
1482
DELISTED
Invesco S&P High Income Infrastructure ETF
GHII
$458K ﹤0.01%
17,153
-4,670
-21% -$123K
ABMD
1483
DELISTED
Abiomed Inc
ABMD
$457K ﹤0.01%
1,756
+110
+7% +$29.2K
JTD
1484
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$457K ﹤0.01%
27,481
-584
-2% -$9.45K
NULG icon
1485
Nuveen ESG Large-Cap Growth ETF
NULG
$2.81B
$456K ﹤0.01%
+12,271
New +$443K
NUW icon
1486
Nuveen AMT-Free Municipal Value Fund
NUW
$253M
$456K ﹤0.01%
27,039
-1,587
-6% -$26.2K
ADSK icon
1487
Autodesk
ADSK
$54.5B
$455K ﹤0.01%
2,794
+510
+22% +$85.7K
CONE
1488
DELISTED
CyrusOne Inc Common Stock
CONE
$455K ﹤0.01%
7,890
+2,181
+38% +$128K
WBT
1489
DELISTED
Welbilt, Inc.
WBT
$454K ﹤0.01%
27,194
+6,303
+30% +$103K
CRI icon
1490
Carter's
CRI
$1.44B
$453K ﹤0.01%
4,641
-329
-7% -$32K
PGP
1491
PIMCO Global StockPLUS & Income Fund
PGP
$103M
$453K ﹤0.01%
36,287
+7,257
+25% +$90K
EXPO icon
1492
Exponent
EXPO
$3.24B
$452K ﹤0.01%
7,714
-527
-6% -$30K
PGEN icon
1493
Precigen
PGEN
$2.32B
$452K ﹤0.01%
58,956
+2,600
+5% +$14K
USCR
1494
DELISTED
U S Concrete, Inc.
USCR
$451K ﹤0.01%
9,085
-13,810
-60% -$644K
CMA
1495
DELISTED
Comerica
CMA
$450K ﹤0.01%
6,190
+69
+1% +$5.13K
AIA icon
1496
iShares Asia 50 ETF
AIA
$5.07B
$448K ﹤0.01%
7,318
-1,143
-14% -$69.3K
LADR
1497
Ladder Capital
LADR
$1.27B
$448K ﹤0.01%
26,970
+11,042
+69% +$184K
BZUN
1498
Baozun
BZUN
$168M
$447K ﹤0.01%
+8,970
New +$387K
TRTN
1499
DELISTED
Triton International Limited
TRTN
$447K ﹤0.01%
13,650
+1,045
+8% +$33.1K
APLE icon
1500
Apple Hospitality REIT
APLE
$3.75B
$446K ﹤0.01%
28,146
+738
+3% +$12K

Similar funds

Cambridge Investment Research Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Cambridge Investment Research Advisors held 2,433 positions worth $10.9B, up 4.1% from $10.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2019 filing shows 160 new, 1,129 increased, 851 reduced and 234 closed positions. Its largest new stake was WisdomTree International ESG Fund: 441,613 shares worth $10.6M. The largest sale was Vanguard S&P 500 ETF, an estimated $38M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2019 buy was WisdomTree International ESG Fund: 441,613 shares worth $10.6M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q2 2019, an estimated $27M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2019 reduction was Vanguard S&P 500 ETF, cutting an estimated $38M.
  • Cambridge Investment Research Advisors fully exited DuPont de Nemours in Q2 2019, selling an estimated $17.5M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $10.9B portfolio in Q2 2019.
  • Cambridge Investment Research Advisors opened 160 new positions and closed 234 in Q2 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $10.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2019, filed 15 Aug 2019.